Dianthus Therapeutics, Inc. /DE/ (DNTH) Insider Trading

Name: Dianthus Therapeutics, Inc. /DE/ (DNTH) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 18, 2026): CARR EDWARD (CHIEF ACCOUNTING OFFICER): Exercise/Conversion of 20,000 shares, $357.6K.

Get alerted when insiders trade DNTH

Email address

Loading company data...

Loading company details...